Vicki Moore, PhD

Contributing Writer https://www.dermatologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Skin Cancer

Incidence of Melanoma Diagnosis, Biopsy Parallel Skin Screening Uptake

Vicki Moore, PhD

June 1, 2022

Researchers sought to determine if the incidence of melanoma diagnoses and biopsies increased with a greater uptake of skin screenings.

“‘Trended strongly’ is code for ‘we failed to meet statistical significance,’” remarked one expert, when she was asked to scrutinize the conclusions of a recent post hoc analysis.

Skin Cancer

Risks of Nonkeratinocyte Skin Cancers Higher in Solid Organ Transplant Recipients

Vicki Moore, PhD

April 15, 2022

A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.

Association Between Cabozantinib and Skin Reactions in Patients with Urothelial Carcinoma

General Dermatology

Cutaneous Adverse Effects Common With Enfortumab Vedotin for Urothelial Cancer

Vicki Moore, PhD

March 23, 2022

Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.

General Medicine

COVID-19 Vaccination and Vaccine-Induced Immune Thrombotic Thrombocytopenia

Vicki Moore, PhD

January 31, 2022

Researchers sought to determine the pathology behind possible vaccine-induced immune thrombocytopenia and thrombosis following COVID-19 vaccinations.

Skin Cancer

Analysis Demonstrates Predictive Capacity of 4 Staging Systems for Cutaneous Squamous Cell Carcinoma

Vicki Moore, PhD

January 26, 2022

Staging systems were analyzed for specificity, positive predictive value, negative predictive value, concordance index, and other parameters.

Skin Cancer

Analysis Demonstrates Predictive Capacity of 4 Staging Systems for Cutaneous Squamous Cell Carcinoma

Vicki Moore, PhD

January 24, 2022

Staging systems were analyzed for specificity, positive predictive value, negative predictive value, concordance index, and other parameters.

General Medicine

Requirements for Meaningful Involvement of Social Workers in Palliative Care

Vicki Moore, PhD

January 5, 2022

Researchers performing a literature review identified and described several requirements for meaningful involvement of social workers in palliative care.

Skin Cancer

Risk of Nonmelanoma Skin Cancer Associated With Exposure to Ruxolitinib

Vicki Moore, PhD

December 9, 2021

Results of a 10-year retrospective study suggests a higher risk of nonmelanoma skin cancer in patients with polycythemia vera or myelofibrosis after ruxolitinib exposure.